Posts

Dr. Elad Anter Blog interview

Image
The focus of my career is the study of arrhythmia mechanisms utilizing physiologically relevant large animal models. This research is stimulated by a clinical practice focused on treating patients with complex arrhythmias, particularly those who had failed standard therapies. My research laboratory develops animal models of human-like rhythm disorders with a particular focus on ventricular tachycardia and ventricular fibrillation, for which current treatment options are limited and/or suboptimal. These models are created by selective balloon occlusion of one or more coronary arteries resulting in structural and electrical ventricular remodeling (i.e., “arrhythmogenic substrate”) and subsequent development of arrhythmias. Models for atrial arrhythmias, including atrial tachycardia and fibrillation are created by ablation-induced scar formation which promotes the development of these arrhythmias. Animals are survived for variable periods, allowing them to study the natural history

Drugs & Devices in 2018 - Elad Anter

ELAD ANTER Listed Specialty: Clinical Cardiac Electrophysiology 75 FRANCIS ST, BOSTON, MA, 02115-6110 Drugs & Devices in 2018 Totals listed below account for all payments from  that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below. Product Name                                                                     Product Type          Payments RHYTHMIA Device $24,994 THERAPIES Device $24,685 GENERAL THERAPIES Device $22,287 PAYMENTS WITH NO LISTED PRODUCT N/A $13,763 NAVISTAR Device $6,971 CLINICAL TRIAL PRODUCT Device $1,138 CARTO 3 SYSTEM Device $170